martes, 5 de mayo de 2020

Cystic Fibrosis News Today Daily Digest

 

Cystic Fibrosis Weekly Update

Contents:

CHMP Favors Expanding Kalydeco Label to Include Young Children With R117H Mutation

May 04, 2020 07:00 am | Marisa Wexler MS



Kalydeco, CFThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion for a label extension of the cystic fibrosis (CF) treatment Kalydeco (ivacaftor). If approved by the European Commission, the extension would allow Kalydeco use in patients 6 months and older who weigh at least five kg (about […]
The post CHMP Favors Expanding Kalydeco Label to Include Young Children With R117H Mutation appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike CHMP Favors Expanding Kalydeco Label to Include Young Children With R117H Mutation on Facebook
 

Recent News

NORD Webinar Outlines COVID-19 Response on Financial, Policy Fronts
The Counseling Connection
Vertex Joins with Affinia Therapeutics to Develop Gene Therapies for CF
Orkambi Helps to Promote Glucose Tolerance in CF Patients, Study Finds
Help! Quarantine Is Making Me Less Compliant

No hay comentarios:

Publicar un comentario